Busse Convenience Kits Recalled: Drug Swabs Face Manufacturing Validation Uncertainty
Professional Disposables International's swab and swabstick drug products, sold in Busse Convenience kits, are recalled due to uncertainty about whether manufacturing validation test methods were adequate.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Class II FDA recall with no reported illnesses or injuries. The hazard is a theoretical manufacturing validation concern rather than a known active danger. Meets criteria for High severity as a risk-of-harm product before injury has been reported.
Plain-English summary
Busse Convenience kits contain swab and swabstick drug products manufactured by Professional Disposables International (PDI). These products are being recalled due to uncertainty about the adequacy of the validation test methods used during manufacturing.
The concern is that the manufacturing process may not have been properly validated, meaning the products might not meet required specifications or quality standards. Parties in possession of these kits should contact Busse Hospital Disposables for further information and instructions.
The recalled product
- Product
- Nerve Block Tray Catalog Number: 6796R3
- Manufacturer
- Busse Hospital Disposables, Inc.
- Category
- Drug
- Hazard
- inadequate-validation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Numbers: 2031026 2031218 2130212 2130896 UDI: 00849233015944
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27